Based in Wiltshire
Turnover of £334,000, with an adjusted EBITDA of £230,000.
Developed innovative microscope substrates used for carrying out indirect immunofluorescence assays.
The products are used to diagnose autoimmune diseases, such as coeliac disease, pernicious anaemia, and Hashimoto's thyroiditis, as well as connective tissue disorders such as systemic lupus erythematosus, Sjögren's syndrome, and Raynaud's.
Offers bespoke slide production and produces a variety of tissue combinations.
Built strong relationships with medical product suppliers.
Products are distributed and utilised across the world, including in the UK, Europe, the UAE, India, and Australia.
Over two decades in operation.
Operates from leasehold laboratory premises rented for circa £9,000 per annum.
Offered for sale to facilitate retirement plans.
Offers invited.
